logo

For the Inventor, By the Inventor

Shanghai, China

Fei Yang

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Abbisko Therapeutics Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Yang. Retrieved from https://idiyas.com/inventor/fei-yang-5nj1rnmq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:

goldMedal3 out of 5 
 
Abbisko Therapeutics Co., Ltd.
 patents

Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents
1. 12753164 - Pyrimidine-4,6-diamine derivative, a preparation method therefor, and a pharmaceutical application thereof (2026-10-06),
2. 12649727 - EFGR inhibitor, preparation method therefor and application thereof (2026-06-09),
3. 12552811 - Immunosuppressant, and preparation method therefor and use thereof (2026-02-17),

Title: Fei Yang: Innovator in Immunosuppressant Development

Introduction

Fei Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology through his innovative research and development of new therapeutic agents. His work focuses on creating effective treatments for various diseases, including cancers and immune-related disorders.

Latest Patents

Fei Yang holds a patent for an immunosuppressant, which includes a preparation method and its uses. The patent describes an immunosuppressant with a specific structure, which can be utilized in the development of drugs aimed at preventing and treating cancers, immune-related diseases, communicable diseases, infectious diseases, and metabolic diseases mediated by PD-1/PD-L1 signal pathways. This innovation is expected to lead to the creation of a new generation of PD-1/PD-L1 inhibitors, showcasing the potential impact of his work on modern medicine.

Career Highlights

Fei Yang is currently associated with Abbisko Therapeutics Co., Ltd., where he continues to advance his research in immunotherapy. His dedication to developing novel therapeutic solutions has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Fei Yang collaborates with notable colleagues, including Yaochang Xu and Baowei Zhao. Their combined expertise contributes to the innovative environment at Abbisko Therapeutics, fostering advancements in drug development.

Conclusion

Fei Yang's contributions to the field of immunology through his patent on immunosuppressants highlight his role as an influential inventor. His work not only addresses critical health challenges but also paves the way for future innovations in cancer treatment and immune system modulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…